Journal of Urgent Care Medicine

Inhaled Insulin Powder Approved For Use in Kids

The U.S. Food and Drug Administration (FDA) has expanded approval for insulin inhalation powder for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes, according to the product manufacturer’s press release. Previously, the inhaled insulin was only approved for adults. The oral inhaler device and insulin inhalation powder deliver insulin into the bloodstream through the lungs, enabling rapid absorption of insulin into systemic circulation. Marketed as Afrezza, …

Semaglutide Compounding Must End, Market Forces Set to Shift

Compounding pharmacies and telehealth companies will ultimately need to stop producing their versions of semaglutide following the resolution of the short-term shortage of the manufacturer’s original brand drug product. Compounding pharmacies were previously allowed to create generic versions of the diabetes and weight loss drug due to supply issues, but with the Food and Drug Administration (FDA) now declaring the shortage over, production and sales must cease by April 22 for pharmacies and May 22 …

Login to JUCM